Literature DB >> 3680534

ELISA for human IgG and IgM anti-lipopolysaccharide antibodies with indirect standardization.

A Fomsgaard1, B Dinesen.   

Abstract

A new attempt to standardize ELISAs for the quantitation of human IgM and IgG anti-lipopolysaccharide antibodies (anti-LPS), without the use of a specific standard material, is described. Sandwich ELISAs for total IgG and IgM were combined with indirect ELISAs for anti-LPS IgG and IgM antibodies on a 96-well microtest plate using identical assay conditions. The concentration of specific IgG or IgM anti-LPS was read on the respective standard curve for total IgG or IgM. The results were corrected for residual immunoreactivity remaining unbound in the wells after one sample incubation in the combined assays. The quantitative results of IgG anti-LPS correlated well with results obtained using an ELISA with direct standardization (r = 0.969). 28 mg/l of IgM anti-LPS was found as median value among 121 blood donors using the described ELISA principle. Binding studies demonstrated a lower apparent affinity of donor anti-LPS IgM than anti-IgG.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680534     DOI: 10.1080/15321818708057032

Source DB:  PubMed          Journal:  J Immunoassay        ISSN: 0197-1522


  9 in total

1.  New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women.

Authors:  F X Lü
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens.

Authors:  M A Freudenberg; A Fomsgaard; I Mitov; C Galanos
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

3.  Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  T Y Ling; T J Sims; H A Chen; C W Whitney; B J Moncla; L D Engel; R C Page
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

4.  Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  A Fomsgaard; B Dinesen; G H Shand; T Pressler; N Høiby
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

5.  Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992.

Authors:  P K Holder; S E Maslanka; L B Pais; J Dykes; B D Plikaytis; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

6.  Unexpectedly high levels of some presumably protective secretory immunoglobulin A antibodies to dental plaque bacteria in salivas of both caries-resistant and caries-susceptible subjects.

Authors:  H Hocini; S Iscaki; J P Bouvet; J Pillot
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  A Fomsgaard; N Høiby; G H Shand; R S Conrad; C Galanos
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.

Authors:  R G Cowan; G B Winnie
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

9.  Development of a high-throughput flexible quantitative suspension array assay for IgG against multiple Plasmodium falciparum antigens.

Authors:  Itziar Ubillos; Joseph J Campo; Alfons Jiménez; Carlota Dobaño
Journal:  Malar J       Date:  2018-05-29       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.